Meta-analysis of genotype-guided vs standard dosing of vitamin K antagonists
The American Journal of Cardiology | Jan 22, 2018
Kheiri B, et al. - This study entailed comparison between genotype-guided vitamin K antagonist (VKA) and standard dosing algorithms, via an updated meta-analysis of all randomized clinical trials (RCTs). Findings showed that genotype-guided VKA dosing vs standard dosing algorithms can improve the time in therapeutic range (TTR) and attenuate the risk for bleeding episodes.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
